Wouter Herman Zwart

Wouter Herman Zwart is a clinical researcher at Leiden University Medical Center's Faculty of Medicine, Department of Surgery, specializing in rectal cancer treatment optimization. His work centers on the international RAPIDO trial, investigating total neoadjuvant therapy versus conventional chemoradiotherapy for high-risk locally advanced rectal cancer.

His research interests focus on neoadjuvant therapy sequencing, oncological outcomes after pathological complete response, and perineal wound complications following abdominoperineal excision. Key contributions address critical debates in post-operative chemotherapy efficacy and RAPIDO trial methodology.

Recent publications demonstrate evolving trends toward total neoadjuvant therapy as standard care, with emphasis on reducing local recurrence while managing surgical complications. His work integrates surgical oncology, radiation therapy, and medical oncology perspectives.

Zwart actively collaborates within the RAPIDO trial consortium, contributing to high-impact clinical evidence through peer-reviewed publications in journals like European Journal of Cancer and Annals of Oncology. His research receives significant attention with 24 Scopus citations for the 2024 oncological outcomes paper.

He operates within multidisciplinary teams focused on rectal cancer innovation, particularly through the RAPIDO trial framework which involves European clinical centers. Current work prioritizes refining treatment algorithms based on pathological response and complication profiles.